Compound details
L-3-Cyanoalanine
| Compound ID | CDAMM02334 |
|---|---|
| Common name | L-3-Cyanoalanine | IUPAC name | 2-amino-3-cyanopropanoic acid |
| Molecular formula | C4H6N2O2 |
| Retention time | 0.56 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 115.051 | Theoretical mz | 115.05 |
| Error | 5.42 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.4018 |
| Inchi key | BXRLWGXPSRYJDZ-YEQUQEJONA-N |
|---|---|
| Smiles | N#CCC(N)C(=O)O |
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SEA |
| O00222 | GRM8 | Metabotropic glutamate receptor 8 | T77548 | SEA |
| P43005 | SLC1A1 | Excitatory amino acid transporter 3 | T31721 | SEA |
| P39086 | GRIK1 | Glutamate receptor ionotropic kainate 1 | T73495 | SEA |
| Q13002 | GRIK2 | Glutamate receptor ionotropic kainate 2 | T58178 | SEA |
| O15303 | GRM6 | Metabotropic glutamate receptor 6 | T55956 | SEA |
| P42261 | GRIA1 | Glutamate receptor ionotropic, AMPA 1 | T33584 | SEA |
| Q16478 | GRIK5 | Glutamate receptor ionotropic kainate 5 | T87930 | SEA |
| Q13003 | GRIK3 | Glutamate receptor ionotropic kainate 3 | T68876 | SEA |
| P42262 | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | T42392 | SEA |
| P07101 | TH | Tyrosine 3-hydroxylase | T62390 | SEA |
| Q16719 | KYNU | Kynureninase | T99912 | SEA |
| Q07075 | ENPEP | Aminopeptidase A | T31956 | SEA |
| Q01650 | SLC7A5 | L-type amino acid transporter 1 (by homology) | T48330 | SEA |
| Q9UPY5 | SLC7A11 | Cystine/glutamate transporter | T11615 | SEA |
| P00480 | OTC | Ornithine transcarbamylase | T52098 | SEA |
| P42263 | GRIA3 | Glutamate receptor AMPA 3 | T62391 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T73495 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P39086 | GRIK1 |
| T73495 | DI0396 | Substance abuse | [ICD-11: 6C40] | P39086 | GRIK1 |
| T33584 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42261 | GRIA1 |
| T42392 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42262 | GRIA2 |
| T62390 | DI0019 | Adrenomedullary hyperfunction | [ICD-11: 5A75] | P07101 | TH |
| T62390 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P07101 | TH |
| T99912 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q16719 | KYNU |
| T99912 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q16719 | KYNU |
| T31956 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q07075 | ENPEP |
| T11615 | DI0054 | Body-focused behaviour disorder | [ICD-11: 6B25] | Q9UPY5 | SLC7A11 |
| T52098 | DI0258 | Metabolism inborn error | [ICD-11: 5C50] | P00480 | OTC |
| T62391 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42263 | GRIA3 |